Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadja Ebert

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 25, 2015
[Progression-free survival of patients with locally advanced NSCLC not improved by consolidation chemotherapy after concurrent chemoradiation]Nadja Ebert, Michael Baumann
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2015
Radiation-induced lung damage - Clinical risk profiles and predictive imaging on their way to risk-adapted individualized treatment planning?Nadja Ebert, Michael Baumann, Esther G C Troost
International Journal of Radiation Biology|March 22, 2019
Cancer stem cells in radiation response: current views and future perspectives in radiation oncologyClaudia Peitzsch, Ina Kurth, Nadja Ebert, et al.
Molecular Oncology|May 29, 2020
What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyondMichael Baumann, Nadja Ebert, Ina Kurth, et al.
Frontiers in Cardiovascular Medicine|July 17, 2023
Experimental renal transplantation in rats improves cardiac dysfunction caused by chronic kidney disease while LVH persistsLinda Hagmayer, Christina Mayer, Nadja Ebert, et al.
British Journal of Pharmacology|November 10, 2020
The dipeptidyl peptidase 4 inhibitor linagliptin ameliorates renal injury and accelerated resolution in a rat model of crescentic nephritisAnna-Lena Mayer, Iris Scheitacker, Nadja Ebert, et al.
Radiation Oncology (London, England)|December 3, 2014
Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenograftsKristin Gurtner, Nadja Ebert, Dorothee Pfitzmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 5, 2021
Sample-size calculation for preclinical dose-response experiments using heterogeneous tumour modelsWilly Ciecior, Nadja Ebert, Nathalie Borgeaud, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
Preclinical trial comparing radiotherapy alone versus standard radiochemotherapy in three human papilloma virus (HPV) negative and three HPV-positive head and neck squamous cell carcinoma (HNSCC) xenograft tumour modelsChiara Valentini, Nadja Ebert, Lydia Koi, et al.
Frontiers in Immunology|July 21, 2018
Epistatic Interactions Between Mutations of Deoxyribonuclease 1-Like 3 and the Inhibitory Fc Gamma Receptor IIB Result in Very Early and Massive Autoantibodies Against Double-Stranded DNAThomas Weisenburger, Bettina von Neubeck, Andrea Schneider, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 25, 2015
[Progression-free survival of patients with locally advanced NSCLC not improved by consolidation chemotherapy after concurrent chemoradiation]Nadja Ebert, Michael Baumann
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2015
Radiation-induced lung damage - Clinical risk profiles and predictive imaging on their way to risk-adapted individualized treatment planning?Nadja Ebert, Michael Baumann, Esther G C Troost
International Journal of Radiation Biology|March 22, 2019
Cancer stem cells in radiation response: current views and future perspectives in radiation oncologyClaudia Peitzsch, Ina Kurth, Nadja Ebert, et al.
Molecular Oncology|May 29, 2020
What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyondMichael Baumann, Nadja Ebert, Ina Kurth, et al.
Frontiers in Cardiovascular Medicine|July 17, 2023
Experimental renal transplantation in rats improves cardiac dysfunction caused by chronic kidney disease while LVH persistsLinda Hagmayer, Christina Mayer, Nadja Ebert, et al.
British Journal of Pharmacology|November 10, 2020
The dipeptidyl peptidase 4 inhibitor linagliptin ameliorates renal injury and accelerated resolution in a rat model of crescentic nephritisAnna-Lena Mayer, Iris Scheitacker, Nadja Ebert, et al.
Radiation Oncology (London, England)|December 3, 2014
Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenograftsKristin Gurtner, Nadja Ebert, Dorothee Pfitzmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 5, 2021
Sample-size calculation for preclinical dose-response experiments using heterogeneous tumour modelsWilly Ciecior, Nadja Ebert, Nathalie Borgeaud, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
Preclinical trial comparing radiotherapy alone versus standard radiochemotherapy in three human papilloma virus (HPV) negative and three HPV-positive head and neck squamous cell carcinoma (HNSCC) xenograft tumour modelsChiara Valentini, Nadja Ebert, Lydia Koi, et al.
Frontiers in Immunology|July 21, 2018
Epistatic Interactions Between Mutations of Deoxyribonuclease 1-Like 3 and the Inhibitory Fc Gamma Receptor IIB Result in Very Early and Massive Autoantibodies Against Double-Stranded DNAThomas Weisenburger, Bettina von Neubeck, Andrea Schneider, et al.
Pageof 3